← FDA DRUG APPROVALS

FDA ANDA · ANDA202566

MODAFINIL

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA202566
TYPE
ANDA
ORIGINAL APPROVAL
2012-09-27
LATEST ACTION
2020-12-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MODAFINILPrescription
MODAFINIL 200MG · TABLET · ORAL
MODAFINILPrescription
MODAFINIL 100MG · TABLET · ORAL

Approval history

2020-12-18Labeling · Supplement 5 · standardAP
2014-11-05Manufacturing (CMC) · Supplement 3 · unknownAP
2012-09-27UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →